Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

SELECTA BIOSCIENCES, INC.

(SELB)
  Rapport
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFondsCommunauté 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur SELECTA BIOSCIENCES, INC.
02/12Cyrus Biotechnology, Inc. announced that it has received $18.352692 million in funding ..
01/12Selecta Biosciences, Swedish Orphan Biovitrum Complete Enrollment in Phase 3 SEL-212 St..
01/12Swedish Orphan Biovitrum, Selecta Biosciences Complete Enrolment In Gout Treatment Stud..
01/12Sobi and Selecta Biosciences announce completion of enrolment in DISSOLVE Phase 3 study..
01/12Selecta Biosciences and Sobi Announce Completion of Enrollment in DISSOLVE Phase 3 Stud..
01/12Selecta Biosciences, Inc. and Biovitrum AB Announces Completion of Enrollment in Dissol..
25/11Selecta Biosciences Says FDA Puts Clinical Hold on SEL-302 Trial, Shares Lower
24/11Selecta Biosciences Says US FDA Places Hold on Methylmalonic Acidemia Trial, Seeks Addi..
24/11SELECTA BIOSCIENCES : Provides Update on Phase 1/2 Clinical Trial of SEL-302 for the Treat..
24/11SELECTA BIOSCIENCES INC : Other Events, Financial Statements and Exhibits (form 8-K)
24/11Selecta Biosciences Provides Update on Phase 1/2 Clinical Trial of SEL-302 for the Trea..
24/11Selecta Biosciences Provides Update on Phase 1/2 Clinical Trial of SEL-302 for the Trea..
24/11Selecta Biosciences, Inc. Provides Update on Phase 1/2 Clinical Trial of SEL-302 for Tr..
11/11Selecta Biosciences to Participate in Jefferies Virtual London Healthcare Conference
09/11Selecta Biosciences Announces Top Line Data from the Phase I SEL-399 AAV Empty Capsid S..
09/11SELECTA BIOSCIENCES INC Management's Discussion and Analysis of Financial Condition an..
09/11Selecta Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Month..
09/11Selecta Biosciences Reports Third Quarter 2021 Financial Results and Provides Business ..
09/11Selecta Biosciences Reports Third Quarter 2021 Financial Results and Provides Business ..
08/11Selecta Biosciences Announces Top Line Data from the Phase I SEL-399 AAV Empty Capsid S..
08/11Selecta Biosciences Announces Top Line Data from the Phase I SEL-399 AAV Empty Capsid S..
08/11Selecta Biosciences, Inc. Announces Top Line Data from the Phase I SEL-399 AAV Empty Ca..
08/11SELECTA BIOSCIENCES INC : Regulation FD Disclosure, Other Events, Financial Statements and..
05/11Selecta Biosciences to Host Conference Call and Webcast to Discuss Third Quarter 2021 F..
26/10Selecta Biosciences Partners With Ginkgo Bioworks to Advance Treatments For Orphan, Rar..
26/10SELECTA BIOSCIENCES INC : Other Events (form 8-K)
26/10Selecta Biosciences, Inc. Enters into Collaboration and License Agreement with Ginkgo B..
26/10Selecta Biosciences and Ginkgo Bioworks Announce Partnership to Advance Treatments for ..
25/10SELECTA BIOSCIENCES INC : Entry into a Material Definitive Agreement, Termination of a Mat..
21/10SELECTA BIOSCIENCES : Working With Genovis to Advance IgG Protease in Gene Therapy, Autoim..
21/10SELECTA BIOSCIENCES INC : Other Events (form 8-K)
21/10GENOVIS : announces exclusive license agreement with Selecta Bioscience to develop and pro..
21/10SELECTA BIOSCIENCES : and Genovis Enter Exclusive License Agreement to Advance Next-Genera..
21/10Genovis AB Announces Exclusive License Agreement with Selecta Bioscience to Develop and..
20/10SELECTA BIOSCIENCES : to Participate in Jefferies Virtual Gene Therapy/Editing Summit
13/10SELECTA BIOSCIENCES : to Present New Data for the ImmTOR™ platform at the ESGCT 28th..
04/10SELECTA BIOSCIENCES : Signs Deal with Takeda Worth Up to $1.12 Billion for Next-Generation..
04/10SELECTA BIOSCIENCES : Working With Takeda Pharmaceutical to Develop Gene Therapies for Lys..
04/10SELECTA BIOSCIENCES INC : Other Events (form 8-K)
04/10Selecta Biosciences Announces Strategic Licensing Agreement with Takeda to Develop Next..
04/10Selecta Biosciences Announces Strategic Licensing Agreement with Takeda to Develop Next..
30/09SELECTA BIOSCIENCES INC : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year,..
30/09Selecta Biosciences, Inc. Files Investigational New Drug Application with the U.S. Food..
21/09Selecta Biosciences to Participate in Cantor Virtual Global Healthcare Conference
20/09SELECTA BIOSCIENCES : Names Kevin Tan Finance Chief
20/09SELECTA BIOSCIENCES : Hires Kevin Tan as CFO
20/09SELECTA BIOSCIENCES INC : Change in Directors or Principal Officers (form 8-K)
20/09SELECTA BIOSCIENCES : Announces Appointment of Kevin Tan as Chief Financial Officer
20/09Selecta Biosciences, Inc. Announces Management Changes
20/09Selecta Biosciences, Inc. Announces Management Changes
20/09SELECTA BIOSCIENCES, INC.(NASDAQGM : SELB) added to S&P Biotechnology Select Industry Inde..
09/09SELECTA BIOSCIENCES : to Participate at the H.C. Wainwright 23rd Annual Global Investment ..
08/09SELECTA BIOSCIENCES : Cyrus Biotechnology Collaborating to Create Engineered Therapeutic P..
08/09SELECTA BIOSCIENCES INC : Other Events (form 8-K)
08/09Selecta Biosciences and Cyrus Biotechnology Enter Collaboration to Create Novel Enginee..
08/09Selecta Biosciences and Cyrus Biotechnology Enters Collaboration to Create Novel Engine..
12/08SELECTA BIOSCIENCES : Management's Discussion and Analysis of Financial Condition and Resu..
12/08SELECTA BIOSCIENCES : Reports Second Quarter 2021 Financial Results and Provides Business ..
12/08Selecta Biosciences, Inc. Reports Earnings Results for the Second Quarter Ended June 30..
12/08Selecta Biosciences Reports Second Quarter 2021 Financial Results and Provides Business..
12/08NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
05/08Selecta Biosciences to Host Conference Call and Webcast to Discuss Second Quarter 2021 ..
02/08SELECTA BIOSCIENCES : to Participate in Upcoming Investor Conferences
26/07SELECTA BIOSCIENCES : Announces Appointment of Jude Samulski, Ph.D. as Gene Therapy Specia..
26/07Selecta Biosciences, Inc. Announces Appointment of Jude Samulski, Ph.D. as Gene Therapy..
26/07Selecta Biosciences Announces the Publication of Data Evaluating ImmTOR with AAV Vector..
08/07Selecta Biosciences to Participate at the William Blair Biotech Focus Conference 2021
24/06SELECTA BIOSCIENCES INC : Change in Directors or Principal Officers (form 8-K)
24/06Selecta Biosciences Appoints Industry Leader Nishan de Silva, M.D. to Board of Director..
24/06Selecta Biosciences, Inc. Appoints Nishan de Silva to Board of Directors
21/06SELECTA BIOSCIENCES INC : Submission of Matters to a Vote of Security Holders (form 8-K)
16/06Selecta Biosciences to Participate at the Raymond James Human Health Innovation Confere..
14/06Selecta Biosciences to Participate at the LifeSci Partners Genetic Medicines Summit 202..
01/06SELECTA BIOSCIENCES : Announces Frontiers in Immunology Publication Showcasing the Enhance..
28/05SELECTA BIOSCIENCES : SELB) Insiders Make Significant Share purchases Continuing the Trend..
1  2  3  4  5  6Suiv.
Prochain événement sur SELECTA BIOSCIENCES, INC.